LakeShore Competitors

LSBCF Stock   0.26  0.14  35.00%   
Analyzing LakeShore Biopharma competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of LakeShore Biopharma to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out LakeShore Biopharma Correlation with its peers.

LakeShore Biopharma vs Relief Therapeutics Correlation

Moving against LakeShore Stock

  0.38CMXHF CSL Limited Earnings Call TomorrowPairCorr
  0.34GME GameStop CorpPairCorr
  0.32IFS Intercorp Financial Earnings Call This WeekPairCorr
  0.31CSLLY CSL Earnings Call TomorrowPairCorr
The LakeShore Biopharma's current Return On Tangible Assets is estimated to increase to -0.08. The current Return On Capital Employed is estimated to decrease to -0.19. At this time, LakeShore Biopharma's Non Currrent Assets Other are most likely to decrease significantly in the upcoming years. The LakeShore Biopharma's current Other Current Assets is estimated to increase to about 102.3 M, while Total Assets are projected to decrease to roughly 1.1 B.
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of LakeShore Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.010.278.33
Details
Intrinsic
Valuation
LowRealHigh
0.010.258.31
Details

LakeShore Biopharma Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between LakeShore Biopharma and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of LakeShore and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of LakeShore Biopharma does not affect the price movement of the other competitor.

High positive correlations

KMSTFACOGF
IMMPFIGXT
ACOGFIGXT
KMSTFIGXT
EMMLFIGXT
IBXNFIGXT
  

High negative correlations

RLFTDPMXSF
RLFTDOCEL
PMXSFOCEL
RLFTDDMTTF
PMXSFDMTTF
OCELDMTTF

Risk-Adjusted Indicators

There is a big difference between LakeShore Stock performing well and LakeShore Biopharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze LakeShore Biopharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
IGXT  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
IMMPF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
ACOGF  4.45 (0.20) 0.00  0.16  0.00 
 9.94 
 65.10 
KMSTF  5.28 (1.37) 0.00 (1.22) 0.00 
 10.12 
 39.40 
EMMLF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
IBXNF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
DMTTF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
OCEL  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
PMXSF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
RLFTD  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 

LakeShore Biopharma Competitive Analysis

The better you understand LakeShore Biopharma competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, LakeShore Biopharma's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across LakeShore Biopharma's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
LSBCF IGXT ACOGF KMSTF
 35.00 
 0.26 
LakeShore
 0.00 
 0.17 
Intelgenx
 0.94 
 6.41 
Alpha
 8.81 
 2.47 
Kadimastem
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Total Debt
Return On Equity
Z Score
Return On Asset
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Target Price
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Information Ratio
Value At Risk

LakeShore Biopharma Competition Performance Charts

Five steps to successful analysis of LakeShore Biopharma Competition

LakeShore Biopharma's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by LakeShore Biopharma in relation to its competition. LakeShore Biopharma's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of LakeShore Biopharma in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact LakeShore Biopharma's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to LakeShore Biopharma, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your LakeShore Biopharma position

In addition to having LakeShore Biopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Broad Municipals ETFs Thematic Idea Now

Broad Municipals ETFs
Broad Municipals ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Municipals ETFs theme has 56 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Municipals ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether LakeShore Biopharma is a strong investment it is important to analyze LakeShore Biopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LakeShore Biopharma's future performance. For an informed investment choice regarding LakeShore Stock, refer to the following important reports:
Check out LakeShore Biopharma Correlation with its peers.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Can Biotechnology industry sustain growth momentum? Does LakeShore have expansion opportunities? Factors like these will boost the valuation of LakeShore Biopharma. Expected growth trajectory for LakeShore significantly influences the price investors are willing to assign. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating LakeShore Biopharma demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Understanding LakeShore Biopharma requires distinguishing between market price and book value, where the latter reflects LakeShore's accounting equity. The concept of intrinsic value - what LakeShore Biopharma's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push LakeShore Biopharma's price substantially above or below its fundamental value.
Understanding that LakeShore Biopharma's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether LakeShore Biopharma represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, LakeShore Biopharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.